Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel green synthesis of risperidone intermediate avoiding POCl3. High yield, scalable process for reliable pharmaceutical intermediate supply.
Patent CN110092746B reveals a green, high-yield route for 2-amino-5-halopyridines using 4-cyano-1-butyne, offering significant cost reduction and supply chain stability for API manufacturing.
Patent CN109776381B details a green aqueous synthesis for spiro indolones using quaternary ammonium iodide, offering significant cost reduction and supply chain reliability.
Patent CN112110951A reveals a novel aqueous-phase radical coupling method for Bryostatin C-ring precursors, offering significant cost reduction in fine chemical manufacturing and enhanced supply chain reliability.
Novel nickel-catalyzed route offers high-purity dibenzocycloheptane intermediates with streamlined scalability and reduced environmental impact for global supply chains.
Discover the novel sulfuric acid hydrolysis route for DL-pantolactone in patent CN114773295A. Achieve high purity Vitamin B5 intermediates with reduced wastewater and solvent-free extraction.
Patent CN111087315A reveals a novel aqueous hydrogenation route for Eltrombopag intermediate BPCA, offering superior purity and reduced manufacturing costs for pharmaceutical supply chains.
Patent CN108997193B reveals a cobalt-catalyzed C-H activation method for difluoroalkyl heterocycles, offering cost-effective synthesis for pharma and agrochemical applications.
Patent CN111909089B reveals a high-speed counter-current chromatography method for purifying 950U77, offering superior yield and purity for pharmaceutical quality control.
Patent CN109988090B reveals a green Rh-catalyzed route for tetrahydropyrroles. Offers high diastereoselectivity and mild conditions for pharma intermediates.
Novel Ru-catalyzed route for (S)-duloxetine intermediate offers high ee and yield without nitrogen protection, reducing manufacturing costs.
Patent CN112341417A details a novel light/copper co-catalyzed route for polysubstituted furans, offering mild conditions and enhanced supply chain reliability for pharmaceutical intermediates.
Patent CN114832862A reveals a cost-effective nickel-catalyzed route for fluorinated isoquinoline-1,3-diones, offering significant supply chain advantages for pharmaceutical intermediate manufacturing.
Novel patent CN106905305A details efficient Empagliflozin synthesis offering supply chain stability and cost reduction for pharmaceutical manufacturing partners globally.
Patent CN119306557A reveals mild two-step synthesis for β-trifluoromethyl enamines. Enables cost reduction and scalable supply for pharmaceutical intermediates.
Novel patent CN117924283A details high-yield spiro compound synthesis offering supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing.
Novel chiral synthesis route for octahydro-2H-pyrrolo[3,4-c]pyridine derivatives offering high purity and scalable pharmaceutical intermediate production capabilities.
Patent CN112441875B reveals a green copper photocatalytic route for 9-trifluoromethyl-9,10-dihydrophenanthrene, offering mild conditions and high atom economy for pharmaceutical intermediates.
Patent CN101973954A reveals a green, aqueous synthesis route for 3,4-dihydro-1,3-oxazin-2-ones, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN114149364A reveals a robust Ullmann coupling route for sulfonamide intermediates, offering superior purity and scalable manufacturing for global pharmaceutical supply chains.